MS-DRG 815

Principal Diagnosis - Pdx

• E32.8 Other diseases of thymus
• E32.9 Disease of thymus, unspecified
• I88.1 Chronic lymphadenitis, except mesenteric
• I88.8 Other nonspecific lymphadenitis
• I88.9 Nonspecific lymphadenitis, unspecified
• I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes
• I89.9 Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
• L04.0 Acute lymphadenitis of face, head and neck
• L04.1 Acute lymphadenitis of trunk
• L04.2 Acute lymphadenitis of upper limb
• L04.3 Acute lymphadenitis of lower limb
• L04.8 Acute lymphadenitis of other sites
• L04.9 Acute lymphadenitis, unspecified
• Q89.01 Asplenia (congenital)
• Q89.09 Congenital malformations of spleen
• R16.1 Splenomegaly, not elsewhere classified
• R59.0 Localized enlarged lymph nodes
• R59.1 Generalized enlarged lymph nodes
• R59.9 Enlarged lymph nodes, unspecified
• R75 Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
• R76.0 Raised antibody titer
• R76.8 Other specified abnormal immunological findings in serum
• R76.9 Abnormal immunological finding in serum, unspecified
• S36.00XA Unspecified injury of spleen, initial encounter
• S36.020A Minor contusion of spleen, initial encounter
• S36.021A Major contusion of spleen, initial encounter
• S36.029A Unspecified contusion of spleen, initial encounter
• S36.030A Superficial (capsular) laceration of spleen, initial encounter
• S36.031A Moderate laceration of spleen, initial encounter
• S36.032A Major laceration of spleen, initial encounter
• S36.039A Unspecified laceration of spleen, initial encounter
• S36.09XA Other injury of spleen, initial encounter
• T80.82XA Complication of immune effector cellular therapy, initial encounter
• Z94.81 Bone marrow transplant status
• Z94.84 Stem cells transplant status